Business
Tandem Diabetes Care Announces Appointment of Sandra Beaver to Board of Directors
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced the
About this update from Tandem Diabetes Care, Inc.
[{"type":"text","content":" SAN DIEGO--(BUSINESS WIRE)--\nTandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Sandra Beaver to its board of directors effective November 7, 2025. Ms. Beaver joins the board as an independent director and will serve on the board’s Audit Committee and Cybersecurity and Data Oversight Committee.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112460451/en/Sandra Beaver joins Tandem Diabetes Care Board of Directors.\n“We welcome Sandra to our Board of Directors at this pivotal stage in Tandem’s evolution,” said John Sheridan, president and CEO. “Sandra is a dynamic finance executive whose experience and insight will be invaluable in helping guide our growth, particularly as we deliver transformative digital health solutions, while scaling efficiently and reaching new markets and geographies.”\n\n\n“I look forward to joining Tandem’s Board of Directors,” said Ms. Beaver. “As a global financial and healthcare leader, I see tremendous opportunity for Tandem to continue driving innovation and executing against their strategy to create long-term, sustainable growth that benefits the diabetes community and shareholders alike.”\n\n\nMs. Beaver has more than 20 years of strategic and operational finance experience globally and across many industries including healthcare, medical devices, gaming, enterprise technology and manufacturing. Ms. Beaver is the CFO at Lyra Health, a leading provider of mental health solutions, overseeing finance, accounting, investor relations, facilities, procurement and corporate development. Before starting this role in June 2025, she served as CFO at Evolus, a publicly traded medical aesthetics company, for three years. Before Evolus, Ms. Beaver held senior finance positions at global data and technology company, Experian, and global gaming company, IGT. Ms. Beaver holds a Bachelor of Business Administration from University of Massachusetts and a Professional Designation in Relational Database Design from UCLA.\n\n\nAbout Tandem Diabetes Care, Inc.\n\n\nTandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creat...